“…Although antibodies to soluble liver antigen/liver-pancreas (anti-SLA/LP) are highly specific markers for AIH in both AIH-1 and AIH-2 [ 153 , 154 ], none was positive for anti-SLA in 154 Japanese patients with type 1 AIH, anti-SLA/LP positivity seems to be unusual in APASL group [ 155 ]. The presence of an autoantibody is a common feature of AIH, in acute-onset AIH or corticosteroid-treated AIH, autoantibodies can be absent or loss [ 156 , 157 ]. It was reported that in Japan, ANA negative or less than 1:40 were seen in 29% of severe or fulminant AIH, and 39% of acute-onset AIH patients [ 102 , 142 ].…”